{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T11:13:22Z","timestamp":1788866002586,"version":"build-2803163510"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T00:00:00Z","timestamp":1786147200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":31,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Oncogene amplification on extrachromosomal DNA is a common driver of tumor progression and is associated with acquired drug resistance and poor patient survival. While bulk whole genome sequencing studies have revealed the landscape of genes amplified on extrachromosomal DNA in tumors, it remains challenging to study the subclonal heterogeneity and functional (e.g., transcriptomic) consequences of extrachromosomal DNA on tumors. To address this, we introduce\n                    <jats:italic>scAmp<\/jats:italic>\n                    : a probabilistic algorithm for detecting and analyzing extrachromosomal DNA from single-cell datasets. Using well-characterized cell lines, we demonstrate that\n                    <jats:italic>scAmp<\/jats:italic>\n                    has improved specificity over bulk genome sequencing in predicting extrachromosomal DNA status and can resolve the status of chromosomal amplifications that were historically extrachromosomal. We further showcase\n                    <jats:italic>scAmp<\/jats:italic>\n                    by analyzing 73 patient tumors profiled with single-cell assay for transposase-accessible chromatin by sequencing, where we characterize the subclonal evolution of subclones with extrachromosomal DNA and identify the effect of these amplifications on the chromatin accessibility landscape of cancer cells. Finally, we provide proof-of-concept analyses that\n                    <jats:italic>scAmp<\/jats:italic>\n                    aids in the detection of extrachromosomal DNA from clinical histopathology assays. Together, we anticipate that\n                    <jats:italic>scAmp<\/jats:italic>\n                    will broadly enable further studies \u2013 both retrospective and prospective \u2013 that dissect critical questions of how extrachromosomal DNAs affect cancer cells and the tumors in which they reside.\n                  <\/jats:p>","DOI":"10.1038\/s41467-026-76417-3","type":"journal-article","created":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T18:13:15Z","timestamp":1786212795000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["scAmp enables focal gene amplification analysis from single-cell data"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0363-4493","authenticated-orcid":false,"given":"Matthew G.","family":"Jones","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9971-2961","authenticated-orcid":false,"given":"Natasha E.","family":"Weiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3662-4662","authenticated-orcid":false,"given":"King L.","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4846-8812","authenticated-orcid":false,"given":"Xiaowei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangya","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4391-979X","authenticated-orcid":false,"given":"Jens","family":"Luebeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditi","family":"Gnanasekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9761-3422","authenticated-orcid":false,"given":"Ivy Tsz-Lo","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0309-6680","authenticated-orcid":false,"given":"Brooke E.","family":"Howitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellis J.","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1164-1252","authenticated-orcid":false,"given":"Kevin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1810-4337","authenticated-orcid":false,"given":"John C.","family":"Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Kraft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeh","family":"Valiollah Pour Amiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leena","family":"Satpathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5810-6241","authenticated-orcid":false,"given":"Vineet","family":"Bafna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4560-2211","authenticated-orcid":false,"given":"Paul S.","family":"Mischel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9459-4393","authenticated-orcid":false,"given":"Howard Y.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,8]]},"reference":[{"key":"76417_CR1","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/nature08822","volume":"463","author":"R Beroukhim","year":"2010","unstructured":"Beroukhim, R. et al. The landscape of somatic copy-number alteration across human cancers. Nature 463, 899\u2013905 (2010).","journal-title":"Nature"},{"key":"76417_CR2","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1038\/s41586-022-04738-6","volume":"606","author":"CD Steele","year":"2022","unstructured":"Steele, C. D. et al. Signatures of copy number alterations in human cancer. Nature 606, 984\u2013991 (2022).","journal-title":"Nature"},{"key":"76417_CR3","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/s41588-020-0678-2","volume":"52","author":"H Kim","year":"2020","unstructured":"Kim, H. et al. Extrachromosomal DNA is associated with oncogene amplification and poor outcome across multiple cancers. Nat. Genet. 52, 891\u2013897 (2020).","journal-title":"Nat. Genet."},{"key":"76417_CR4","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41586-024-08107-3","volume":"635","author":"C Bailey","year":"2024","unstructured":"Bailey, C. et al. Origins and impact of extrachromosomal DNA. Nature 635, 193\u2013200 (2024).","journal-title":"Nature"},{"key":"76417_CR5","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/nature21356","volume":"543","author":"KM Turner","year":"2017","unstructured":"Turner, K. M. et al. Extrachromosomal oncogene amplification drives tumour evolution and genetic heterogeneity. Nature 543, 122\u2013125 (2017).","journal-title":"Nature"},{"key":"76417_CR6","doi-asserted-by":"publisher","unstructured":"Luebeck, J. et al. AmpliconSuite: an end-to-end workflow for analyzing focal amplifications in cancer genomes. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2024.05.06.592768 (2024).","DOI":"10.1101\/2024.05.06.592768"},{"key":"76417_CR7","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1038\/s41588-024-01949-7","volume":"56","author":"H Kim","year":"2024","unstructured":"Kim, H. et al. Mapping extrachromosomal DNA amplifications during cancer progression. Nat. Genet. 56, 2447\u20132454 (2024).","journal-title":"Nat. Genet."},{"key":"76417_CR8","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/s41586-023-05937-5","volume":"616","author":"J Luebeck","year":"2023","unstructured":"Luebeck, J. et al. Extrachromosomal DNA in the cancerous transformation of Barrett\u2019s esophagus. Nature 616, 798\u2013805 (2023).","journal-title":"Nature"},{"key":"76417_CR9","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1101\/gr.279131.124","volume":"34","author":"K Zhu","year":"2024","unstructured":"Zhu, K. et al. CoRAL accurately resolves extrachromosomal DNA genome structures with long-read sequencing. Genome Res. 34, 1344\u20131354 (2024).","journal-title":"Genome Res."},{"key":"76417_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-08200-y","volume":"10","author":"V Deshpande","year":"2019","unstructured":"Deshpande, V. et al. Exploring the landscape of focal amplifications in cancer using AmpliconArchitect. Nat. Commun. 10, 392 (2019).","journal-title":"Nat. Commun."},{"key":"76417_CR11","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1038\/s41588-022-01177-x","volume":"54","author":"JT Lange","year":"2022","unstructured":"Lange, J. T. et al. The evolutionary dynamics of extrachromosomal DNA in human cancers. Nat. Genet. 54, 1527\u20131533 (2022).","journal-title":"Nat. Genet."},{"key":"76417_CR12","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1038\/s41588-023-01551-3","volume":"55","author":"OS Chapman","year":"2023","unstructured":"Chapman, O. S. et al. Circular extrachromosomal DNA promotes tumor heterogeneity in high-risk medulloblastoma. Nat. Genet. 55, 2189\u20132199 (2023).","journal-title":"Nat. Genet."},{"key":"76417_CR13","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/s41586-025-08721-9","volume":"640","author":"E Fiorini","year":"2025","unstructured":"Fiorini, E. et al. MYC ecDNA promotes intratumour heterogeneity and plasticity in PDAC. Nature 640, 811\u2013820 (2025).","journal-title":"Nature"},{"key":"76417_CR14","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41586-024-07861-8","volume":"635","author":"KL Hung","year":"2024","unstructured":"Hung, K. L. et al. Coordinated inheritance of extrachromosomal DNAs in cancer cells. Nature 635, 201\u2013209 (2024).","journal-title":"Nature"},{"key":"76417_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56670-8","volume":"16","author":"S Raeisi Dehkordi","year":"2025","unstructured":"Raeisi Dehkordi, S. et al. Breakage fusion bridge cycles drive high oncogene number with moderate intratumoural heterogeneity. Nat. Commun. 16, 1497 (2025).","journal-title":"Nat. Commun."},{"key":"76417_CR16","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.cell.2019.10.026","volume":"179","author":"E Laks","year":"2019","unstructured":"Laks, E. et al. Clonal decomposition and DNA replication states defined by scaled single-cell genome sequencing. Cell 179, 1207\u20131221.e22 (2019).","journal-title":"Cell"},{"key":"76417_CR17","doi-asserted-by":"publisher","first-page":"3968","DOI":"10.1016\/j.cell.2023.07.024","volume":"186","author":"K Wang","year":"2023","unstructured":"Wang, K. et al. Archival single-cell genomics reveals persistent subclones during DCIS progression. Cell 186, 3968\u20133982.e15 (2023).","journal-title":"Cell"},{"key":"76417_CR18","doi-asserted-by":"publisher","unstructured":"Lee, J. J.-K. et al. Evolution of oncogene amplification across 86,000 cancer cell genomes. Preprint at bioRxiv https:\/\/doi.org\/10.64898\/2026.02.12.705658 (2026).","DOI":"10.64898\/2026.02.12.705658"},{"key":"76417_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-026-03933-2","volume":"27","author":"JD Hendriksen","year":"2026","unstructured":"Hendriksen, J. D. et al. Resolving clonal evolution and selection of extrachromosomal DNA at single-cell resolution. Genome Biol. 27, 10 (2026).","journal-title":"Genome Biol."},{"key":"76417_CR20","first-page":"4914","volume":"39","author":"LA Quinn","year":"1979","unstructured":"Quinn, L. A., Moore, G. E., Morgan, R. T. & Woods, L. K. Cell lines from human colon carcinoma with unusual cell products, double minutes, and homogeneously staining regions. Cancer Res. 39, 4914\u20134924 (1979).","journal-title":"Cancer Res."},{"key":"76417_CR21","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1126\/science.1241328","volume":"343","author":"DA Nathanson","year":"2014","unstructured":"Nathanson, D. A. et al. Targeted therapy resistance mediated by dynamic regulation of extrachromosomal mutant EGFR DNA. Science 343, 72\u201376 (2014).","journal-title":"Science"},{"key":"76417_CR22","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/s41586-021-04116-8","volume":"600","author":"KL Hung","year":"2021","unstructured":"Hung, K. L. et al. ecDNA hubs drive cooperative intermolecular oncogene expression. Nature 600, 731\u2013736 (2021).","journal-title":"Nature"},{"key":"76417_CR23","first-page":"2773","volume":"50","author":"JG Park","year":"1990","unstructured":"Park, J. G. et al. Characteristics of cell lines established from human gastric carcinoma. Cancer Res. 50, 2773\u20132780 (1990).","journal-title":"Cancer Res."},{"key":"76417_CR24","doi-asserted-by":"publisher","DOI":"10.1093\/narcan\/zcae035","volume":"6","author":"J Fessler","year":"2024","unstructured":"Fessler, J. et al. CytoCellDB: a comprehensive resource for exploring extrachromosomal DNA in cancer cell lines. NAR Cancer 6, zcae035 (2024).","journal-title":"NAR Cancer"},{"key":"76417_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50387-w","volume":"15","author":"KL Mortenson","year":"2024","unstructured":"Mortenson, K. L. et al. 3D genomic analysis reveals novel enhancer-hijacking caused by complex structural alterations that drive oncogene overexpression. Nat. Commun. 15, 6130 (2024).","journal-title":"Nat. Commun."},{"key":"76417_CR26","doi-asserted-by":"publisher","DOI":"10.1126\/science.adk9217","volume":"385","author":"L Sundaram","year":"2024","unstructured":"Sundaram, L. et al. Single-cell chromatin accessibility reveals malignant regulatory programs in primary human cancers. Science 385, eadk9217 (2024).","journal-title":"Science"},{"key":"76417_CR27","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1158\/2159-8290.CD-20-0936","volume":"12","author":"K Song","year":"2022","unstructured":"Song, K. et al. Plasticity of extrachromosomal and intrachromosomal BRAF amplifications in overcoming targeted therapy dosage challenges. Cancer Discov. 12, 1046\u20131069 (2022).","journal-title":"Cancer Discov."},{"key":"76417_CR28","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1038\/s41586-025-08973-5","volume":"642","author":"K Okonechnikov","year":"2025","unstructured":"Okonechnikov, K. et al. Oncogene aberrations drive medulloblastoma progression, not initiation. Nature 642, 1062\u20131072 (2025).","journal-title":"Nature"},{"key":"76417_CR29","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1158\/2159-8290.CD-24-1555","volume":"15","author":"I Noorani","year":"2025","unstructured":"Noorani, I. et al. Extrachromosomal DNA-driven oncogene spatial heterogeneity and evolution in glioblastoma. Cancer Discov. 15, 2078\u20132095 (2025).","journal-title":"Cancer Discov."},{"key":"76417_CR30","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/s41586-019-1763-5","volume":"575","author":"S Wu","year":"2019","unstructured":"Wu, S. et al. Circular ecDNA promotes accessible chromatin and high oncogene expression. Nature 575, 699\u2013703 (2019).","journal-title":"Nature"},{"key":"76417_CR31","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1038\/s41587-019-0206-z","volume":"37","author":"AT Satpathy","year":"2019","unstructured":"Satpathy, A. T. et al. Massively parallel single-cell chromatin landscapes of human immune cell development and intratumoral T cell exhaustion. Nat. Biotechnol. 37, 925\u2013936 (2019).","journal-title":"Nat. Biotechnol."},{"key":"76417_CR32","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abg6045","volume":"7","author":"A Nikolic","year":"2021","unstructured":"Nikolic, A. et al. Copy-scAT: deconvoluting single-cell chromatin accessibility of genetic subclones in cancer. Sci. Adv. 7, eabg6045 (2021).","journal-title":"Sci. Adv."},{"key":"76417_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41076-1","volume":"14","author":"A Ramakrishnan","year":"2023","unstructured":"Ramakrishnan, A. et al. epiAneufinder identifies copy number alterations from single-cell ATAC-seq data. Nat. Commun. 14, 5846 (2023).","journal-title":"Nat. Commun."},{"key":"76417_CR34","doi-asserted-by":"publisher","first-page":"6355","DOI":"10.1016\/j.cell.2025.08.012","volume":"188","author":"K Wang","year":"2025","unstructured":"Wang, K. et al. Coalescing single-cell genomes and transcriptomes to decode breast cancer progression. Cell 188, 6355\u20136369.e16 (2025).","journal-title":"Cell"},{"key":"76417_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-020-02000-8","volume":"21","author":"MG Jones","year":"2020","unstructured":"Jones, M. G. et al. Inference of single-cell phylogenies from lineage tracing data using Cassiopeia. Genome Biol. 21, 92 (2020).","journal-title":"Genome Biol."},{"key":"76417_CR36","doi-asserted-by":"publisher","first-page":"e1004873","DOI":"10.1371\/journal.pcbi.1004873","volume":"12","author":"E Talevich","year":"2016","unstructured":"Talevich, E., Shain, A. H., Botton, T. & Bastian, B. C. CNVkit: genome-wide copy number detection and visualization from targeted DNA sequencing. PLoS Comput. Biol. 12, e1004873 (2016).","journal-title":"PLoS Comput. Biol."},{"key":"76417_CR37","unstructured":"Paszke, A. et al. PyTorch: an imperative style, high-performance deep learning library. NeurIPS 8024\u20138035 (2019)."},{"key":"76417_CR38","doi-asserted-by":"crossref","unstructured":"Yi, H. et al. EcDNA-borne structural variants drive oncogenic fusion transcript amplification. Cell 189, 906\u2013921.e20 (2026).","DOI":"10.1016\/j.cell.2025.12.009"},{"key":"76417_CR39","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/s41588-021-00790-6","volume":"53","author":"JM Granja","year":"2021","unstructured":"Granja, J. M. et al. ArchR is a scalable software package for integrative single-cell chromatin accessibility analysis. Nat. Genet. 53, 403\u2013411 (2021).","journal-title":"Nat. Genet."},{"key":"76417_CR40","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon, A. et al. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst. 1, 417\u2013425 (2015).","journal-title":"Cell Syst."},{"key":"76417_CR41","doi-asserted-by":"publisher","unstructured":"Jones, M. et al. Github.com\/jonescompbiolab\/scamp: ScAmp Codebase. https:\/\/doi.org\/10.5281\/ZENODO.20434848 (Zenodo, 2026).","DOI":"10.5281\/ZENODO.20434848"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76417-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76417-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76417-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T11:04:19Z","timestamp":1788865459000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76417-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,8]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["76417"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-76417-3","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,8]]},"assertion":[{"value":"9 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"H.Y.C. is an employee and stockholder of Amgen as of Dec. 16, 2024. H.Y.C. is a co-founder of Accent Therapeutics, Boundless Bio, Cartography Biosciences, Orbital Therapeutics, and was an advisor of 10\u00d7 Genomics, Arsenal Bio, Chroma Medicine, Exai Bio, and Vida Ventures. M.G.J. consults for and holds equity in Tahoe Therapeutics and Factorial Biotechnologies. P.S.M. was a co-founder of Boundless Bio and had equity and consulted for the company. P.S.M. is a co-founder\u00a0of Alterris Oncology; he has equity and consults, for which he is compensated. V.B. is a co-founder, paid consultant, and scientific advisory board member and has equity interests in Boundless Bio and Abterra. The terms of this arrangement have been reviewed and approved by the University of California, San Diego, in accordance with its conflict-of-interest policies. K.K. is an employee and stockholder of Amgen. S.A. is an employee of Amgen. B.H. has received research support from Cartography, Santa Ana Bio, Link Cell Sciences, and Immunogen. B.H. has received consulting\/advisory fees from Cartography, Roche, Leica, Tempus, and AbbVie. V.V.P.A. is a stockholder of Microsoft. The remaining authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"9563"}}